The gene cluster for the biosynthesis of the heterocyclic quinone antibiotic saframycin Mxl of Myxococcus xanthus DM5W15 was inactivated and tagged by TnS insertions. The tagged genes were cloned in Escherichia coli and used to select overlapping cosmid clones spanning 58 kb of the M. xanthus genome.
INTRODUCTION
Saframycins belong to the group of heterocyclic quinone antibiotics including mitomycins and streptonigrin (Nakatsubo et al.,1977; Weinred et al., 1982) which bind covalently to DNA and inhibit cellular DNA and RNA synthesis (Ishiguro et al., 1978 (Ishiguro et al., , 1981 Kishi et al., 1984; Lown e t al., 1982) . Saframycins A, B, C, D and E were isolated first from Streptomyes lavenddae (Arai e t al., 1977 (Arai e t al., , 1980 . Saframycin Mxl is produced by the Gram-negative myxobacterium Myxucocct~s xantbus . Saframycins have antimicrobial (Irschick e t al., 1988) and good antitumour activity (Arai e t al., 1980; Kishi et al., 1984) . Fig. 1 shows the structure of saframycin Mxl (Trowitzsch-Kienast e t al., 1988) . The dimeric N-heterocyclic quinone which is present in all saframycins is derived from two tyrosine molecules and the side chains are derived from glycine and alanine (Mikami etal., 1985) .
The myxobacteria grow in soil and have a complex life cycle with multicellular differentiation. Similar to differentiating actinomyctes and bacilli, they produce a large number of secondary metabolites (Reichenbach, 1986; Reichenbach e t al., 1988) . The knowledge of genes involved in the synthesis of myxobacterial secondary metabolites is however still limited to two gene clusters Abbreviation: CIAP, calf intestine alkaline phosphatase.
The GenBank accession number for the sequence reported in this paper is U24657.
involved in the biosynthesis of the macrolide antibiotics TA (myxovirescin A) from M. x a n t h s (Gerth e t al., 1982; Tolchinsky et al., 1992; Varon e t al., 1992) 0001-9943 0 1995 SGM the latter have been cloned and sequenced, revealing repetitive type I polyketide synthetases (Schupp e t al., 1995; Hopwood & Khosla, 1992 ).
Here we report the cloning in Escbericbia coli of 58 kb contiguous M. xantbtls DNA involved in the biosynthesis of saframycin Mxl . Transposon mutagenesis and gene disruption by homologous recombination in M. xantbtls were used to define a 2 18 kb DNA region involved in antibiotic production, and sequencing of part of this region revealed similarities to peptide synthetases, consistent with the biosynthetic origin of saframycin Mxl.
METHODS
Bacterial strains and plasmids. These are listed in Table 1 . For gene disruption experiments the conjugative plasmids pSUP202 and pCIBl32 were used. For DNA sequencing, fragments were cloned in pBluescript I1 SK( +).
Media and culture conditions. E. coli was grown at 37 OC in Luria broth (LB) or on LB agar. Sarcina lutea was grown at 30 "C on solid DST medium (Oxoid) or in liquid BHI medium (BBL). M. xanthus was grown at 28 "C in S45 medium (3 g casein
w/v, HEPES, pH 7.2), or on solid S46 medium (S45 with 12 g agar 1-'). Antibiotics were used at the following concentrations for E. coli and M. xanthus: ampicillin 50 pg ml-', kanamycin 50 pg ml-', streptomycin 100 pg ml-', tetracycline 10 pg ml-' and chloramphenicol 34 pg ml-'.
Tn5 mutagenesis of M. xanthus DM504/15. An overnight culture of E. coli S17-1 containing pSUP2021 and grown under kanamycin, ampicillin and chloamphenicol selection was diluted 100-fold with LB medium without antibiotics and incubated for a further 6 h. Subsequently 1 x 10' ' cells of this E. coli culture and 5 x lo8 cells of M. xanthus DM504/15 (grown at 28 "C to a cell density of 2 x lo8 ml-' and preincubated for 10 min at 45 "C) were mixed, sedimented (8000 g, 3 min), resuspended in 150 p1 S45 medium and spotted onto S46 agar without antibiotics. After overnight incubation at 28 "C, cells were scraped off the agar and resuspended in 1 ml S45 medium. Portions (100 pl) were plated onto S46 plates containing 100 pg streptomycin ml-' (streptomycin resistance encoded by Tn5is expressed in M. xanthus but not in E. coli: Madozier et al., 1986) and 50 pg kanamycin ml-' and incubated for 6 d at 28 "C.
Biological assay (biotest) for saframycin Mxl production. M. xanthus DM504/15 and its derivatives were grown for 5 d at 28 O C on S46 agar (20 ml per plate) without antibiotics. Agar plugs (3 mm diameter) with single colonies were placed onto DST agar freshly overlaid with 10 ml DST agar at 45 "C and 100 p1 of an overnight culture of Sarcina lutea. After overnight incubation at 30 "C, the inhbition zones of S. lutea were measured. This biotest detects 2 0.5 ng saframycin Mxl.
Colonies of strain DM504/15 produce 10-25 ng saframycin Mxl and inhibition zones of 10-14mm diameter; non-producing mutants did not inhibit growth of S. lutea.
Gene disruption of M. xanthus DM504/15. pCIB132 derivatives were introduced by conjugation into M. xanthus DM504/15 using the same procedure as for the Tn5 mutagenesis. Kanamycin-resistant transconjugants containing plasmids integrated into the genome via homologous recombination were selected. DNA manipulations. Standard genetic techniques for in vitro DNA manipulations and cloning were used (Sambrook et al., 1989) . Genomic DNA preparations were performed as described by Neumann etal. (1992) . For Southern blots and colony hybridizations the digoxigenin labelling and detection kit from Boehringer-Mannheim and Hybond N-N ylon-membranes from Amersham were used. were pooled and ligated to pWE15 digested with BamHI and treated with calf intestine alkaline phosphatase (CIAP). The ligation mixture was packaged in vitro using Gigapack Plus (Stratagene).
Construction of
DNA sequencing. Double-stranded DNA fragments were cloned into pBluescript SK( +) and sequenced by the dideoxy nucleotide chain-termination method (Sanger et al., 1977) with dye-labelled primers and an Applied Biosystems Automated Sequencer (model 373A). Universal primer and oligonucleotide primers designed according to the newly obtained DNA sequences were used.
Computer analysis of DNA and protein sequences. The DNA sequences were assembled and analysed using software Version 1.20 from Applied Biosystems and the UWGCG program package version 8.0 (Devereux et al., 1984) . 
RESULTS
Tn5 mutagenesis of M. xanthus DM504/15 and isolation of saframycin Mxl. non-producers Tn5 and its derivatives have been used to mutagenize M. xantbtrs and to identify and clone a number of genes (Kroos & Kaiser, 1984; Kroos e t al., 1986; Kuner & Kaiser, 1981) . Transposition of Tn5 into the genome occurs after conjugative transfer of the suicide plasmid pSUP2021 from E. coli to M. xantbtls (Saulnier e t al., 1988) . For the saframycin production strain DM504/15, this technique yielded kanamycin-and streptomycinresistant mutants at a frequency of about 1 x per recipient cell. Southern blots using genomic DNA from * Saf+'-, saframycin Mxl production/non-production.
tDerivative of pSUP2021 constructed by reversal of the 5 kb Not1 fragment, followed by removal of the resulting 3 kb BamHI fragment, leaving a unique BamHI cloning site. 
independent Tn5 insertion mutants indicated that the transposon integrated at different sites (data not shown).
In four separate experiments, 21 60 Tn5 integrative mutants of M. xantbtls DM504/15 were generated and screened for saframycin Mxl production using the biological assay. A total of 27 (1.25 %) saframycin Mxl non-producers were found and confirmed by HPLC analysis.
Gene disruption with Tn5-containing DNA fragments derived from saf ramycin M x l non-producers
Genomic DNA of Tn5-containing saframycin Mxl nonproducing mutants AP66/254 and AP70/9-1 was digested with EcoRI (does not cut Tn5, 5.7 kb), ligated to the EcoRI-digested and CIAP-treated conjugative vector pSUP202 and transformed into E. coli S17-1. Two kanamycin-resistant clones were analysed : pAP78/1, derived from AP66/254, contains a 16 kb EcoRI fragment; pAP78/5, derived from AP70/9-1, contains an 8.8 kb EcoRI fragment. Southern blot analysis with a Tn5-specific probe showed that the cloned fragments had the same size as the genomic fragments (Fig. 2 ).
Chromosomal DNA of M. xantbus DM504/15 showed no cross-hybridization with Tn5.
The role of these EcoRI fragments in saframycin Mxl biosynthesis was confirmed by gene disruption in strain M. xantbus DM504/15. Both plasmids gave kanamycinresistant transconjugants, with frequencies of 1-4 x for pAP78/1 and 1.4 x for pAP78/5. Saframycin Mxl production determined by the biotest was abolished in 148/153 (pAP78/1) and in 98/176 (pAP78/5; smaller clone) transconjugants. Southern blot analysis showed that the saframycin non-producing transconjugants contained the plasmids integrated by a single crossover in the genome while in the kanamycin-resistant producer strains Tn5 had transposed to random sites in the genome (data not shown).
Results obtained in the biotest were confirmed by HPLC analysis for three producing and three non-producing transeonjugants from each plasmid: the six strains containing random Tn5 insertions produced between 20 and 24 mg saframycin Mxl 1-l; this is similar to the productivity of the parental strain DM504/15, which produces between 18 and 24 mg saframycin Mxl 1-l. The transconjugants in which the plasmids had integrated by homologous recombination produced no saframycin. These results demonstrated a direct correlation between the cloned fragments in pAP78/1 and pAP78/5 and saframycin Mxl production.
Cloning of the saframycin M x l biosynthesis genes from M. xanthus DM504/15
A cosmid library of M. x a n t h s DM504/15 DNA in pWEl5 was screened with DNA probes derived from the EcoRI inserts of pAP78/1 and pAP78/5. To avoid crosshybridization between the kanamycin-resistance gene of Tn5 and the kanamycin-resistance gene of the vector, the central part of Tn5 was deleted from the EcoRI fragments by digestion with HindIII. As a result two EcoRI/HindIII fragments of 10 and 2.6 kb for pAP78/1 (probe A) and two EcoRIIHindIII fragments of 1.9 and 3-5 kb for pAP78/5 (probe B) were obtained. In a first screening, 2500 colonies were analysed with probe A and probe B. One cosmid clone, pAP93/8 (see Fig. 4 ), hybridized with both DNA probes (Fig. 3a, b) , indicating that the sites of Tn5 insertions in AP66/254 and AP70/9-1 are close to each other (Fig. 4) .
As expected, the chromosomal EcuRI fragments of M.
xantbus DM504/15 detected by probes A and B are about 6 kb (size of Tn5) smaller than the inserts in pAP78/1 and pAP78/5 (Fig. 3) . The EcuRI fragments from the cosmid pAP93/8 are of the same size as the chromosomal fragments, indicating that the complete wild-type fragments have been cloned. Additional screening identified the cosmids pAP101/19 and pAP108/3 (Fig. 4) . Together the cosmids pAP93/8 and pAPlO8/3 cover about 58 kb. Fig. 4 shows restriction maps of the cosmids and of the genomic region they represent.
Size of the region involved in saframycin Mxl biosynthesis
DNA fragments of the three cosmids pAP93/8, pAP101/19 and pAP108/3 were used for gene disruption experiments. Four BamHI and four EcuRI fragments were subcloned into the conjugative plasmid pCIB132 and transformed into the E. culi donor strain S17-1 (Fig. 4) .
All fragments gave kanamycin-resistant (encoded by pCIB132) M. xantbus DM504/15 transconjugants, presumably by homologous recombination, with fre uencies ranging between 1.4 x and 1.5 x 10-. The saframycin Mxl productivity of these transconjugants was determined with the biotest. The six fragments represented by black bars in Fig. 4 abolished biosynthesis of saframycin Mxl after integration. Open bars represent 4 fragments whose integration had no effect on antibiotic production and therefore most probably contain the beginning and the end of the saframycin Mxl biosynthetic gene cluster. To determine the position on the left end of the gene cluster more precisely, plasmid PAP1 13/3 (Fig.  4) was constructed by a partial EcuRI digestion of PAP1 10/11 followed by digestion with EcuRV, infilling and subsequent ligation. This plasmid carries an 8 kb insert and gave saframycin-Mxl-positive transconjugants. Thus the left end of the gene cluster is located within this 2 kb region, Based on these gene disruption experiments, and on the positions of the Tn5 integration sites, the size of the region involved in saframycin Mxl biosynthesis is at least 18 kb (Fig. 4) .
Sequence analysis
The nucleotide sequence (Fig. 5 ) of 5809 bp of the saframycin Mxl biosynthetic gene cluster was determined.
It has an overall G + C content of 71 mol YO, typical for myxobacteria. Analysis of the sequence with the program CODONPREFERENCE (Devereux et a/., 1984) revealed one probably translated ORF (Fig. 5) . The ORF (safA) has more than 1936 amino acids and its start point and stop codon are outside the sequenced region. Sequence comparison using TFASTA (Devereux et al., 1984) 
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LGGHS Numbers between the amino acids indicate the distances between these sequences. The core sequences were defined by Marahiel (1992) .
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EMBL accession number U07359). A COMPARE-DOTPLOT-
analysis (Devereux et al., 1984) of the amino acid sequence of SafA with itself revealed two similar domains of 43 YO identity, SafAl (approximately amino acids 200-800) and SafA2 (approximately amino acids 1300-1 900), of about 600 amino acids and spaced by about 500 amino acids. SafAl and SafA2 show 35 YO identity and 59 % similarity to amino-acid-activating domains of known peptide synthetases. Fig. 6 shows a DOTPLOT comparison with the gramicidin S synthetase I1 from Bacihs brevis. Peptide synthetases are multifunctional enzymes, employing the thiotemplate mechanism (Kleinkauf & von Dohren, 1990) , harbouring domains of about 600 amino acids, containing at least six highly conserved core sequences (Marahiel, 1992) . Fig. 7 shows a comparison of SafAl and SafA2 with different amino-acid-activating domains of peptide synthetases. The core sequences LKAGGA, SGTTG, GELCIGG, TGD, RIELGEIE and LGGHS, as well as the spacing between them, are well conserved in SafAl and SafA2.
DISCUSSION
Two saframycin non-producing mutants of M. xantbtls DM504/15 were isolated after Tn5 mutagenesis. Cloning of the Tn5-containing DNA fragments from these mutants and their integration by homologous recombination (single crossover insertion of suicide plasmids introduced by interspecific RP4-mediated conjugation) into the producer strain DM504/15 (Fig. 4) again gave non-producing mutants. This proved that antibiotic nonproduction was caused by the insertions and not by spontaneously occurring secondary mutations, which are common in some systems (T. Kieser, personal communication).
Saframycin Mxl gene cluster of M~xococcus xantbzu
Cosmid cloning and restriction mapping of the Tn5-containing DNA regions showed that the sites of transposon insertion were about 9 kb apart in the DM504/15 genome (Fig. 4) , suggesting that they are located within a specific saframycin biosynthesis gene cluster. Another possibility would have been that global activators of antibiotic biosynthesis (Adamidis et al., 1990 (Adamidis et al., , 1992 Lawlor et al., 1988) , which tend to be scattered in bacterial genomes, could have been inactivated.
The region containing the non-mutated saframycin biosynthetic gene cluster was cloned in E. coli on three overlapping cosmids (Fig. 4) spanning 58 kb of DNA. Within this region, saframycin production genes were located by gene disruption in a central region of at least 18 kb. The upper limit of the size of the gene cluster cannot be deduced from these experiments because only integration of fragments internal to transcription units is mutagenic.
Sequencing of 5-8 kb of this region (Fig. 5 ) revealed extensive similarity to known peptide synthetases (Figs 6 and 7), providing virtual proof that the gene cluster contains structural genes for saframycin Mxl biosynthesis. Within the deduced amino acid sequence of SafA, two peptide synthetase modules, SafAl and SafA2 (Fig. 6) , were identified on a single ORF, a common feature of peptide synthetases (Cosmina et al., 1993; Smith e t al., 1990; Turgay et al., 1992) . Known active sites and core regions of peptide synthetases (Fig. 7) are conserved in SafAl and SafA2, suggesting that they may both be active and a part of a giant protein. The biological significance of the first core (LKAGGA) is unknown, but the SGTTGXPKG (Gocht & Marahiel, 1994) , the TGD (Gocht & Marahiel, 1994) and the KIRGXRIEL (PavelaVrancic et al., 1994; Tohika et al., 1993) core sequences could be assigned to ATP binding and hydrolysis. The serine of the core sequence LGGXS could be shown to be the site of thioester formation (D'Souza e t Schlumbohm e t al. , 1991 ; Vollenbroich e t al., 1993) and 4'-phosphopantetheine binding (Stein e t al., 1994) . These findings, together with the fact that saframycin Mxl ( Fig.  1 ) is synthesized from amino acids (Trowitzsch-Kienast e t al., 1988) , support the hypothesis that non-ribosomal peptide bond formation via the thiotemplate mechanism (Kleinkauf & von Dohren, 1990 ) is involved in the biosynthetic pathway of saframycin Mxl and that saJA encodes the corresponding peptide synthetase. According to this mechanism, amino acids are activated as aminoacyladenylates by ATP hydrolysis and subsequently covalently bound to the enzyme via carboxyl-thioester linkages. Then, in further steps, transpeptidation and peptide bond formation occur.
It will be necessary to sequence the full length of safA, and further genes involved in saframycin Mxl production, to achieve a precise understanding of the saframycin biosynthetic operon. Nevertheless, the results presented in this study are consistent with findings about antibiotic genes in other myxobacteria, which are arranged as clusters (Schupp et al., 1995; Tolchinsky et al., 1992; Varon et al., 1992) , as well as in other systems (reviewed by Hopwood & Khosla, 1992) . In addition, the genes characterized are similar in their sequence and organization to other antibiotic biosynthesis genes (Cosmina et al., 1993; Rusnak e t al., 1991; Turgay e t al., 1992) . The cloning and characterization of biosynthetic genes for peptide antibiotics produced by myxobacteria is a prerequiste for the understanding of the regulatory mechanisms that govern expression of these secondary metabolites and will provide further insight into the regulation of saframycin Mxl production in M. xantbus.
